Beneficial effect of aggressive low-density lipoprotein apheresis in a familial hypercholesterolemic patient with severe diabetic scleredema

Therapeutic Apheresis

Volumn 5, Issue 6, 2001, Pages 506-512

  Koga, Nobuhiko ^a  

^a SHIN KOGA HOSPITAL   (Japan)

Author keywords

Diabetic scleredema; Familial hypercholesterolemia; Histopathology; Low density lipoprotein apheresis; Magnetic resonance imaging

Indexed keywords

CELLULOSE; DEXTRAN SULFATE; GLIBENCLAMIDE; INSULIN; LOW DENSITY LIPOPROTEIN; PRAVASTATIN; PROBUCOL; VOGLIBOSE;

ADULT; APHERESIS; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE COURSE; EXTRACORPOREAL CIRCULATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HEMADSORPTION; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCLEREDEMA; SKIN BIOPSY;

BLOOD COMPONENT REMOVAL; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; MIDDLE AGED; SCLEREDEMA ADULTORUM;

EID: 0035674314     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2001.00346.x     Document Type: Article

References (37)

1. Diabetic scleredema
2. 1: A case report
3. Severe diabetic scleredema with a wide extension
4. 1
5. A case of diabetic scleredema
6. Diabetic scleredema
7. A trial of acupuncture for diabetic scleredema
8. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)
9. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preoperative ultracentrifuge
10. Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia
11. 1
12. Scleredema diabeticorum: A common and distinct cutaneous manifestation of diabetes mellitus
13. Diabetic scleredema: Clinical and histological studies in patients with non-insulin dependent diabetes mellitus
14. Scleroedema diabeticorum: A minor but often unrecognized complication of diabetes mellitus
15. A case report of diabetic scleredema in a patient with non-insulin-dependent diabetes mellitus
16. Severe scleredema diabeticorum and insulin resistance
17. Immunohistochemical localization of apoprotein B in aortas from hyperlipemic swine
18. Apolipoprotein B accumulation and development of foam cell lesions in coronary arteries of hypercholesterolemic swine
19. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: A multicenter study
20. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-Density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS)
21. Intravascular ultrasound analysis of coronary plaque regression by LDL-apheresis in patients with familial hypercholesterolemia: The LDL-Apheresis Coronary Morphology and Reserve Trial (LACMRT)
22. LDL-Apheresis Atherosclerosis Regression Study (LAARS): Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis
23. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
24. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia
25. LDL-apheresis as a treatment of arteriosclerosis obliterans in the lower extremities: A multicenter study
26. Prognosis of patients with arteriosclerosis obliterans treated with LDL-apheresis
27. LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy
28. Low density lipoprotein apheresis therapy for steroidresistant nephrotic syndrome
29. Single LDL apheresis improves endolthelium-dependent vasodilatation in hypercholesterolemic humans
30. Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
31. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia
32. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor
33. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-densitylipoprotein apheresis
34. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia
35. LDL apheresis reduces the susceptibility of LDL to in vitro oxidation in a diabetic patient with hemodialysis treatment
36. Different effects of two methods of lowdensity lipoprotein apheresis on the coagulation and fibrinolytic systems
37. Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia